Ryan Specialty Holdings, Inc. Stock

Equities

RYAN

US78351F1075

Multiline Insurance & Brokers

Market Closed - Nyse 04:00:02 2024-06-07 pm EDT 5-day change 1st Jan Change
53.85 USD -1.37% Intraday chart for Ryan Specialty Holdings, Inc. -3.03% +25.17%
Sales 2024 * 2.47B Sales 2025 * 2.88B Capitalization 6.41B
Net income 2024 * 237M Net income 2025 * 366M EV / Sales 2024 * 3.05 x
Net Debt 2024 * 1.14B Net Debt 2025 * 823M EV / Sales 2025 * 2.51 x
P/E ratio 2024 *
51.1 x
P/E ratio 2025 *
30.6 x
Employees 4,401
Yield 2024 *
1.08%
Yield 2025 *
0.88%
Free-Float 37.16%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Ryan Specialty Holdings, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 04:40 PM
BofA Securities Initiates Ryan Specialty Group at Buy Rating With $67 Price Target MT
Wolfe Research Downgrades Ryan Specialty Group Holdings to Peer Perform From Outperform MT
Ryan Specialty Q1 Adjusted EPS, Revenue Increase MT
Ryan Specialty Holdings Seeks M&A CI
Transcript : Ryan Specialty Holdings, Inc., Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (RYAN) RYAN SPECIALTY HOLDINGS Reports Q1 EPS $0.35, vs. Street Est of $0.35 MT
Earnings Flash (RYAN) RYAN SPECIALTY HOLDINGS Posts Q1 Revenue $552M, vs. Street Est of $547.3M MT
Ryan Specialty Holdings, Inc. Revises Earnings Guidance for the Year 2024 CI
Ryan Specialty Holdings, Inc. Declares Quarterly Dividend, Payable on May 28, 2024 CI
Ryan Specialty Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Ryan Specialty Holdings, Inc. completed the acquisition of Castel Underwriting Agencies Limited from Arch Financial Holdings (UK) Limited and other minority shareholders for approximately $250 million. CI
Wells Fargo Raises Price Target on Ryan Specialty Group to $58 From $57, Keeps Overweight Rating MT
UBS Raises Ryan Specialty Price Target to $62 From $57, Maintains Buy Rating MT
JPMorgan Adjusts Price Target on Ryan Specialty Group Holdings to $47 From $44, Maintains Underweight Rating MT
More news
1 day-1.37%
1 week-3.03%
Current month-3.03%
1 month+3.20%
3 months-0.77%
6 months+21.78%
Current year+25.17%
More quotes
1 week
53.83
Extreme 53.83
57.09
1 month
52.02
Extreme 52.02
57.09
Current year
41.65
Extreme 41.65
57.09
1 year
41.49
Extreme 41.49
57.09
3 years
25.57
Extreme 25.57
57.09
5 years
25.57
Extreme 25.57
57.09
10 years
25.57
Extreme 25.57
57.09
More quotes
Managers TitleAgeSince
Chief Executive Officer 86 09-12-31
President 63 11-12-31
Director of Finance/CFO 38 10-12-31
Members of the board TitleAgeSince
Director/Board Member 73 21-07-20
Director/Board Member 64 11-12-31
Director/Board Member 66 11-12-31
More insiders
Date Price Change Volume
24-06-07 53.85 -1.37% 445,367
24-06-06 54.6 -3.75% 668,285
24-06-05 56.73 +0.41% 969,534
24-06-04 56.5 -0.46% 531,519
24-06-03 56.76 +2.22% 753,959

Delayed Quote Nyse, June 07, 2024 at 04:00 pm EDT

More quotes
Ryan Specialty Holdings, Inc. is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. The Company provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter with delegated authority from insurance carriers. For retail insurance brokers, it assists in the placement of complex or otherwise hard-to-place risks. For insurance carriers, it works with retail and wholesale insurance brokers to source, onboard, underwrite, and service these same risks. The Company’s Wholesale Brokerage Specialty operates predominantly under the brand RT Specialty along with others, such as RT ProExec and CERT. Its Binding Authority Specialty operates under the RT Specialty and RT Binding Authority brands. Its Underwriting Management Specialty operates under multiple brands, which are collectively referred to as Ryan Specialty Underwriting Managers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
53.85 USD
Average target price
58 USD
Spread / Average Target
+7.71%
Consensus